This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Pohang University of Science and Technology Foundation, Novmetapharma Co., Ltd.. Active years: 2012-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 1,105 
2 out of 15 Years Active: 2012-2020
Title: Kyong Tai Kim: Innovator in Pharmaceutical Composition
Introduction
Kyong Tai Kim is a notable inventor based in Pohang, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the prevention and treatment of diabetes and metabolic diseases. With a total of 4 patents, his work has the potential to impact many lives.
Latest Patents
One of his latest patents is a pharmaceutical composition comprising amodiaquine and an anti-diabetes drug as effective ingredients for the prevention or treatment of diabetes. This invention focuses on controlling side effects from peroxisome proliferator-activated receptor-gamma (PPAR-gamma) activation. The composition aims to prevent or treat conditions such as type 2 diabetes, obesity, dyslipidemia, cardiovascular diseases, and fatty cirrhosis. Another significant patent involves a composition for preventing, alleviating, or treating metabolic diseases, which also contains amodiaquine as an active ingredient. This composition activates both PPAR-gamma and PPAR-alpha, showcasing its innovative approach to metabolic disease management.
Career Highlights
Kyong Tai Kim has worked with reputable organizations, including the Pohang University of Science and Technology Foundation and Novmetapharma Co., Ltd. His experience in these institutions has allowed him to develop and refine his innovative ideas in pharmaceutical research.
Collaborations
Throughout his career, Kyong Tai Kim has collaborated with talented individuals such as Hoe Yune Jung and Sangjune Kim. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Kyong Tai Kim is a distinguished inventor whose work in pharmaceutical compositions has the potential to transform the treatment of diabetes and metabolic diseases. His innovative contributions continue to pave the way for advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile